Pharmacotherapy in Patients with Alzheimer-type Dementia Presenting with Behavioral and Psychological Symptoms of Dementia: A Retrospective Chart Review of 102 Patients Available for 12-month Follow-up after Initiation of Treatment
-
- FUJITA MASAYA
- Department of Psychiatry, Hasegawa Hospital
-
- ISHIZUKA TAKUYA
- Department of Psychiatry, Hasegawa Hospital
この論文をさがす
説明
<p>Objective Alongside non-pharmacological intervention, pharmacotherapy particularly with atypical antipsychotics is assumed to be effective for behavioral and psychological symptoms of dementia (BPSD).</p><p>Methods This retrospective study investigated the effectiveness and safety of pharmacotherapy including antipsychotics in outpatients or inpatients with BPSD.</p><p>Results Of all Alzheimer-type dementia (AD) patients with BPSD initiating treatment between March and August 2011, a total of 102 patients available for 12-month follow-up comprised the subjects in this chart review. Of these, 68 (66.7%) continued treatment in the ambulatory or inpatient setting, with their MMSE scores improved from 17.3 ± 3.6 at baseline to 18.3 ± 3.53, 17.9 ± 3.80 and 17.0 ± 4.14 after 3, 6 and 12 months, respectively. In contrast, their NPI scores were significantly different from 11.7 ± 11.2 at baseline to 4.86 ± 5.40, 3.56 ± 4.65 and 2.27 ± 3.77 after 3, 6 and 12 months, respectively. Of the 36 inpatients available for follow-up, 27 (75%) on concurrent antipsychotics (chlorpromazine [CP] equivalent, 162.2 mg) at baseline remained on concurrent antipsychotics (CP equivalent, 212.5 mg) after 12 months, while, of the 66 outpatients available for follow-up, 13 (19.7%) on concurrent antipsychotics (CP equivalent, 93.4 mg) at baseline remained on concurrent antipsychotics (CP equivalent, 113.0 mg) after 12 months.</p><p>Conclusions Study results confirmed the effectiveness and safety of the study treatment in Japanese AD patients with BPSD for up to 12 months. How best to incorporate antipsychotics into the treatment of BPSD in clinical settings lies in the hands of us Japanese clinicians.</p>
収録刊行物
-
- 順天堂醫事雑誌
-
順天堂醫事雑誌 69 (5), 370-377, 2023-09-29
順天堂医学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390860919505525504
-
- NII書誌ID
- AA1262207X
-
- ISSN
- 21882126
- 21879737
-
- NDL書誌ID
- 033193731
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
-
- 抄録ライセンスフラグ
- 使用不可